当前位置:首页 - 行情中心 - 海尔生物(688139) - 财务分析 - 现金流量表

海尔生物

(688139)

  

流通市值:107.16亿  总市值:107.16亿
流通股本:3.16亿   总股本:3.16亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金574,350,307.752,444,397,545.971,681,571,829.291,156,363,413.19
  收到的税费返还11,370,131.9338,320,562.7628,202,468.0324,623,824.35
  收到其他与经营活动有关的现金15,551,245.6554,358,007.7949,860,321.2918,378,285.07
  经营活动现金流入小计601,271,685.332,537,076,116.521,759,634,618.611,199,365,522.61
  购买商品、接受劳务支付的现金274,950,369.931,193,137,579.66880,864,392.6650,033,142.42
  支付给职工以及为职工支付的现金185,693,586.39647,242,346.78481,731,863.06333,363,699.84
  支付的各项税费58,510,149.45138,101,835.69101,364,948.8571,377,311.15
  支付其他与经营活动有关的现金70,440,352.21290,699,981.21213,030,277.78108,951,302.44
  经营活动现金流出小计589,594,457.982,269,181,743.341,676,991,482.291,163,725,455.85
  经营活动产生的现金流量净额11,677,227.35267,894,373.1882,643,136.3235,640,066.76
二、投资活动产生的现金流量:
  收回投资收到的现金783,440,0003,955,764,141.173,139,860,0002,279,900,000
  取得投资收益收到的现金1,778,538.1622,067,445.8917,124,148.9113,120,658.21
  处置固定资产、无形资产和其他长期资产收回的现金净额100455,473.89358,28090,338.23
  投资活动现金流入小计785,218,638.163,978,287,060.953,157,342,428.912,293,110,996.44
  购建固定资产、无形资产和其他长期资产支付的现金15,578,197.98119,254,456.2480,869,727.0968,398,152.12
  投资支付的现金526,100,0003,785,640,0002,944,800,0002,175,569,771.63
  取得子公司及其他营业单位支付的现金-56,647,50056,647,50047,647,500
  投资活动现金流出小计541,678,197.983,961,541,956.243,082,317,227.092,291,615,423.75
  投资活动产生的现金流量净额243,540,440.1816,745,104.7175,025,201.821,495,572.69
三、筹资活动产生的现金流量:
  吸收投资收到的现金-225,000--
  其中:子公司吸收少数股东投资收到的现金-225,000--
  取得借款收到的现金5,000,00020,000,00020,000,00020,000,000
  收到其他与筹资活动有关的现金-717,966,461.12538,303,291.65358,868,861.1
  筹资活动现金流入小计5,000,000738,191,461.12558,303,291.65378,868,861.1
  偿还债务支付的现金5,010,00010,010,00010,000,00010,000,000
  分配股利、利润或偿付利息支付的现金153,575.33150,295,702.61148,510,068.41148,454,174.72
  其中:子公司支付给少数股东的股利、利润-2,938,276.5--
  支付其他与筹资活动有关的现金1,469,892.73846,622,175.04645,325,067.21435,948,901.54
  筹资活动现金流出小计6,633,468.061,006,927,877.65803,835,135.62594,403,076.26
  筹资活动产生的现金流量净额-1,633,468.06-268,736,416.53-245,531,843.97-215,534,215.16
四、汇率变动对现金及现金等价物的影响-7,434,796.113,199,531.71,655,825.715,555,997.04
五、现金及现金等价物净增加额246,149,403.3619,102,593.06-86,207,680.12-172,842,578.67
  加:期初现金及现金等价物余额553,806,623.74534,704,030.68534,704,030.68534,704,030.68
  期末现金及现金等价物余额799,956,027.1553,806,623.74448,496,350.56361,861,452.01
补充资料:
  净利润-255,132,280.57-147,213,041.4
  资产减值准备-8,507,764.46-2,932,521.61
  固定资产和投资性房地产折旧-71,800,978.78-35,622,434.12
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-71,032,333.78-35,238,111.62
    投资性房地产折旧-768,645-384,322.5
  无形资产摊销-48,373,937.95-24,164,032.34
  长期待摊费用摊销-2,328,495.2-1,145,098.75
  递延收益摊销--3,263,645.16--1,631,822.66
  处置固定资产、无形资产和其他长期资产的损失--632,148.71-18,792.77
  固定资产报废损失-1,225,721.96-171,159.07
  公允价值变动损失-494,110.38--1,894,977.61
  财务费用--21,561,678.65--13,611,814.62
  投资损失--27,308,983.33--15,907,644.87
  递延所得税--31,895,649.67--13,314,357.87
  其中:递延所得税资产减少--23,666,047.65--10,199,357.76
    递延所得税负债增加--8,229,602.02--3,115,000.11
  存货的减少--18,645,073.77-29,355,937.96
  经营性应收项目的减少--68,683,543.49--95,632,254.5
  经营性应付项目的增加-34,073,537.69--79,564,536.38
  现金的期末余额-553,806,623.74-361,861,452.01
  减:现金的期初余额-534,704,030.68-534,704,030.68
  现金及现金等价物的净增加额-19,102,593.06--172,842,578.67
公告日期2026-04-302026-03-282025-10-312025-08-27
审计意见(境内)标准无保留意见
TOP↑